Literature DB >> 31032137

Alcohol-Induced Hepatic Steatosis: A Comparative Study to Identify Possible Indicator(s) of Alcoholic Fatty Liver Disease.

Harshica Fernando1, Kamlesh K Bhopale2, Shakuntala S Kondraganti3, Bhupendra S Kaphalia4, G A Shakeel Ansari4.   

Abstract

BACKGROUND: Fatty liver is an early sign of both nonalcoholic and alcoholic fatty liver diseases. Ethanol feeding using a Lieber-DeCarli liquid diet (LD) model which contains 35% fat to rats or mice is a well-established model for alcoholic fatty liver. However, LD diet alone can also induce fatty liver and its differential metabolic profile may be able to differentiate steatosis induced by LD versus LD plus ethanol.
PURPOSE: We investigated the lipidomic differences in the livers of Sprague-Dawley (SD) rats fed a pellet diet (PD), LD and liquid ethanol diet (LED) for six weeks. STUDY
DESIGN: Male Sprague Dawley rats were fed with nonalcoholic diets PD, LD or LED (ethanol in LD) for six weeks. Lipids were extracted and analyzed by nuclear magnetic resonance (NMR)- based metabolomics. The NMR data obtained was analyzed by multivariate Principal Component Analysis (PCA) and Spotfire DecisionSite 9.0 software to compare PD versus LD and LD versus LED groups.
RESULTS: PCA of the NMR spectral data of livers of both comparisons showed a clear separation of PD from LD group and LD from LED group indicating differences in lipid profiles which corresponded with changes in total lipid weights. LD showed increases for cholesterol, esterified cholesterol, cholesterol acetate and triglycerides with decreases for fatty acyl chain, diallylic and allylic protons, while the LED showed increases in esterified cholesterol, cholesterol acetate, fatty acid methyl esters, allylic protons and some triglyceride protons with decreases in free cholesterol and phosphatidylcholine (PC).
CONCLUSION: Our data suggest that altered lipid signature or PC levels could be an indicator to differentiate between nonalcoholic versus alcoholic fatty liver.

Entities:  

Keywords:  Alcoholic fatty liver; lipids; nonalcoholic fatty liver; phosphatidylcholine; steatosis

Year:  2018        PMID: 31032137      PMCID: PMC6483099          DOI: 10.4303/jdar/236040

Source DB:  PubMed          Journal:  J Drug Alcohol Res        ISSN: 2090-8342


  52 in total

Review 1.  Metabonomics: a platform for studying drug toxicity and gene function.

Authors:  Jeremy K Nicholson; John Connelly; John C Lindon; Elaine Holmes
Journal:  Nat Rev Drug Discov       Date:  2002-02       Impact factor: 84.694

Review 2.  Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease.

Authors:  Amin A Nanji
Journal:  Alcohol       Date:  2004-08       Impact factor: 2.405

Review 3.  Lipidomics and lipid profiling in metabolomics.

Authors:  J Bruce German; Laura A Gillies; Jennifer T Smilowitz; Angela M Zivkovic; Steven M Watkins
Journal:  Curr Opin Lipidol       Date:  2007-02       Impact factor: 4.776

4.  1H-NMR and 13C-NMR lipid profiles of human renal tissues.

Authors:  V Tugnoli; G Bottura; G Fini; A Reggiani; A Tinti; A Trinchero; M R Tosi
Journal:  Biopolymers       Date:  2003       Impact factor: 2.505

5.  Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy.

Authors:  Marlies Oostendorp; Udo F H Engelke; Michèl A A P Willemsen; Ron A Wevers
Journal:  Clin Chem       Date:  2006-05-18       Impact factor: 8.327

6.  The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.

Authors:  Zhaoyu Li; Luis B Agellon; Theresa M Allen; Masato Umeda; Larry Jewell; Andrew Mason; Dennis E Vance
Journal:  Cell Metab       Date:  2006-05       Impact factor: 27.287

7.  Metabolic basis of ethanol-induced hepatic and pancreatic injury in hepatic alcohol dehydrogenase deficient deer mice.

Authors:  Kamlesh K Bhopale; Hai Wu; Paul J Boor; Vsevolod L Popov; G A S Ansari; Bhupendra S Kaphalia
Journal:  Alcohol       Date:  2006-07       Impact factor: 2.405

Review 8.  Nonalcoholic fatty liver disease: a review of current understanding and future impact.

Authors:  Michael Charlton
Journal:  Clin Gastroenterol Hepatol       Date:  2004-12       Impact factor: 11.382

9.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

Authors:  Kanji Yamaguchi; Liu Yang; Shannon McCall; Jiawen Huang; Xing Xian Yu; Sanjay K Pandey; Sanjay Bhanot; Brett P Monia; Yin-Xiong Li; Anna Mae Diehl
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 10.  High-fat diets: modeling the metabolic disorders of human obesity in rodents.

Authors:  Roland Buettner; Jürgen Schölmerich; L Cornelius Bollheimer
Journal:  Obesity (Silver Spring)       Date:  2007-04       Impact factor: 5.002

View more
  1 in total

1.  Proton NMR Enables the Absolute Quantification of Aqueous Metabolites and Lipid Classes in Unique Mouse Liver Samples.

Authors:  Aurélien Amiel; Marie Tremblay-Franco; Roselyne Gautier; Simon Ducheix; Alexandra Montagner; Arnaud Polizzi; Laurent Debrauwer; Hervé Guillou; Justine Bertrand-Michel; Cécile Canlet
Journal:  Metabolites       Date:  2019-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.